Investor Presentaiton
Building the Platform - Eurofins 2012 - Eurofins 2020
* eurofins
2012
2015
2019
2020
2012-2020 A
+8 years
Revenues (€ m)
1,044
1,950
4,563
5,439
23% CAGR
Employees
10,890
18,382
43,320
50,000
21% CAGR
(average FTE)
Number of laboratories
170
225
>800
>800
Over 4x
(year-end)
Number of countries
34
39
>50
>50
>16
Number of business
lines with global
leadership
4 (Food and feed,
Environment,
BioPharma product
testing, Drug
discovery services)
Number of future
1 (Genomics)
oriented business lines
4 (Food and feed,
Environment,
7 (Food and feed, Environment,
BioPharma product testing,
Drug discovery services,
Agroscience CRO services,
testing, Drug discovery Specialised Material Sciences
BioPharma product
services)
2 (Genomics, Clinical
Genetics)
testing, Cosmetics Testing)
5 (Genomics (#2 globally),
Forensics (#1 in Europe),
Clinical Genetics, Pharma
CDMO, Eurofins Technologies)
7 (Food and feed, Environment,
BioPharma product testing,
Drug discovery services,
Agroscience CRO services,
Specialised Material Sciences
testing, Cosmetics Testing)
5 (Genomics (#2 globally),
Forensics (#1 in Europe),
Clinical Genetics, Pharma
CDMO, Eurofins Technologies)
+3
+4
36View entire presentation